Co-Authors
This is a "connection" page, showing publications co-authored by Jörg Timm and Johannes Fischer.
Connection Strength
0.118
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
Score: 0.059
-
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure. Front Immunol. 2021; 12:645989.
Score: 0.059